WCN26-7719 IMMUNOSUPPRESSIVE THERAPY IN IgA NEPHROPATHY ASSOCIATED WITH CHRONIC LIVER DISEASE

Read full text Summarise with VIRAT
Authors: Venkat Praneeth Reddy Kalva, Prathyusha Bollam, Pallavi Kumari, Niranjana Rekha Paladugu, Sujith Reddy R, Anand V. Kulkarni, Sai Ram Reddy Keithi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

IgA nephropathy (IgAN) associated with chronic liver disease (CLD), considered a secondary form of IgAN, is a poorly characterized condition with limited treatment guidance. While immunosuppressive therapy (IMM) is actively being studied in primary IgAN, patients with secondary IgAN are often excluded from clinical trials due to concerns about worsening hepatic dysfunction.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106300–106300
Publication date
25 March 2026
Language
EN